ORIC Pharmaceuticals, Inc. (ORIC) Financials

ORIC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 404.7 million 23.4 million
March 31, 2026 436.8 million 21.2 million
Dec. 31, 2025 411.0 million 26.6 million
Sept. 30, 2025 431.2 million 24.3 million

ORIC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -32.0 million 7.1 million
March 31, 2026 -32.4 million 6.9 million
Dec. 31, 2025 -22.9 million 6.3 million
Sept. 30, 2025 -25.1 million 5.6 million

ORIC Net Income

No data available :(

ORIC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 264.8 million - 3.3 million
March 31, 2026 281.9 million - 3.3 million
Dec. 31, 2025 281.5 million 4.1 million 4.1 million
Sept. 30, 2025 287.1 million - 3.3 million

ORIC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 108.0 million
March 31, 2026 105.5 million
Dec. 31, 2025 87.8 million
Sept. 30, 2025 99.0 million

ORIC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 356000 36.3 million 9.0 million -
March 31, 2026 2000 31.4 million 8.2 million -
Dec. 31, 2025 387000 25.9 million 8.7 million -
Sept. 30, 2025 35000 28.8 million 7.9 million -

ORIC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 264000
March 31, 2026 - -
Dec. 31, 2025 - 320000
Sept. 30, 2025 - -

ORIC

Price: $13.87

52 week price:
7.23
14.93

Earnings Per Share: -1.30 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 145300

Market Capitalization: 1.4 billion

Links: